Schwarz Dygos Wheeler Investment Advisors LLC Has $518,000 Position in GE HealthCare Technologies Inc. $GEHC

Schwarz Dygos Wheeler Investment Advisors LLC lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 25.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,987 shares of the company’s stock after purchasing an additional 1,406 shares during the quarter. Schwarz Dygos Wheeler Investment Advisors LLC’s holdings in GE HealthCare Technologies were worth $518,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. N.E.W. Advisory Services LLC bought a new stake in shares of GE HealthCare Technologies during the first quarter worth $25,000. Allianz SE lifted its stake in shares of GE HealthCare Technologies by 165.2% in the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after acquiring an additional 218 shares during the last quarter. Gladwyn Financial Advisors Inc. acquired a new stake in shares of GE HealthCare Technologies during the 2nd quarter valued at $34,000. Game Plan Financial Advisors LLC grew its position in GE HealthCare Technologies by 295.3% during the 2nd quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock worth $37,000 after acquiring an additional 375 shares during the last quarter. Finally, Zions Bancorporation National Association UT acquired a new position in GE HealthCare Technologies in the 1st quarter worth about $42,000. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Wells Fargo & Company cut their price target on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a research note on Thursday, October 30th. Morgan Stanley raised their price objective on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a report on Thursday, October 30th. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Tuesday. Citigroup cut shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and decreased their price target for the company from $93.00 to $83.00 in a research report on Tuesday, October 7th. Finally, Zacks Research lowered shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $86.10.

GE HealthCare Technologies Stock Down 1.3%

GE HealthCare Technologies stock opened at $73.97 on Friday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The firm has a 50 day moving average price of $75.20 and a two-hundred day moving average price of $73.65. The firm has a market cap of $33.69 billion, a price-to-earnings ratio of 15.28, a PEG ratio of 2.82 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. During the same period in the prior year, the firm posted $1.14 EPS. The company’s quarterly revenue was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.89%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.